Piezosurgical Buccal Plate Repositioning Technique for Horizontal Alveolar Ridge Augmentation

Alveolar Bone Loss Clinical Trial

Official title:

Evaluation of Piezosurgical Buccal Plate Repositioning Technique for Horizontal Alveolar Ridge Augmentation Comparing Between Two Different Grafting Materials (a Randomized Clinical Trial)

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05317039
• Other study ID #: Piezosurgery_2021
• Status: Active, not recruiting
• Phase: N/A
• Start date: August 15, 2021
• Est. completion date: June 30, 2022

Study information

• Verified date: March 2022
• Source: Alexandria University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Achieving prosthetically driven implant placement is a highly predictable treatment modality with reliable long-term results. Different surgical procedures have been used as a solution for reconstructing of the alveolar ridge with deficient volume. In the present study we demonstrate a modified alveolar ridge split technique for horizontal alveolar ridge augmentation (buccal plate repositioning technique) using the piezotome surgery. Evaluation of the effect of silica-calcium phosphate nanocomposite (SCPC) graft material versus demineralized freeze dried bone allograft (DFBA) in horizontal alveolar ridge augmentation before implant insertion will be performed.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 18
• Est. completion date: June 30, 2022
• Est. primary completion date: June 30, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 50 Years

Eligibility

Inclusion Criteria:

• Patients with horizontal atrophy of the posterior mandible with pristine residual alveolar crest width from 2 to 4 mm.

• Augmented area length in the mesial-distal direction of less than 20 mm.

• Adequate physically healthy condition.

Exclusion Criteria:

• A systemic disease that would contraindicate oral surgical treatment.

• Treated patients who had undergone therapy involving radiation

• Patients who had received bone resection as part of an oncological treatment after a bone augmentation procedure.

• Patients are subjected to intravenous and/or oral bisphosphonate therapy after the bone augmentation procedure.

Related Conditions & MeSH terms

• Alveolar Bone Loss

Intervention

Other:
• silica-calcium phosphate nanocomposite SCPC
Patients will be treated with the buccal plate repositioning technique and grafted with SCPC then the grafted defect will be covered with a platelet-rich fibrin membrane.
• freezed dried bone
Patients will be treated with the buccal plate repositioning technique and grafted using DFDBA. then the grafted defect will be covered with a platelet-rich fibrin membrane.

Locations

Country	Name	City	State
Egypt	Alexandria Faculty of Dentistry	Alexandria

Sponsors (1)

Lead Sponsor	Collaborator
Hams Hamed Abdelrahman

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	change in alveolar ridge width	All patients will receive a CBCT scan; immediately after surgery and at 6 months post-operatively. The images will be analyzed using OnDemand3D software (Cybermed Inc) CBCT analyzing software and compared to the pre-operative scan for alveolar ridge width evaluation.	at baseline and 6 months